Bio-Techne

Bio-Techne

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$299,712
$321,192
$311,415
$295,877
Gross Profit
196,623
211,394
208,288
191,277
EBITDA
36,603
91,899
98,616
77,664
EBIT
67,758
74,447
52,955
Net Income
28,293
54,611
51,057
38,009
Net Change In Cash
299,712
321,192
311,415
295,877
Free Cash Flow
67,196
86,936
77,575
76,490
Cash
350,036
264,712
209,819
172,879
Basic Shares
157,928
157,009
156,943
156,999

Annual Financials

Values in thousands2026-06-302025-06-302024-06-302023-06-30
Revenue
$1,215,039
$1,219,635
$1,159,060
$1,136,702
Gross Profit
799,071
790,272
769,725
769,815
EBITDA
343,444
216,875
313,136
457,112
EBIT
246,085
106,972
201,425
349,874
Net Income
181,862
73,400
168,105
285,263
Net Change In Cash
1,215,039
1,219,635
1,159,060
1,136,702
Cost of Revenue
11,360
Free Cash Flow
263,223
256,550
236,104
216,149
Cash
264,712
162,186
151,791
180,571
Basic Shares
157,009
159,717
160,774
161,855

Earnings Calls

QuarterEPS
2026-09-30
$0.36
2026-06-30
$0.49
2026-03-31
$0.53
2025-12-31
$0.46